Hacksell U, Svensson U, Nilsson J L, Hjorth S, Carlsson A, Wikström H, Lindenberg P, Sanchez D
J Med Chem. 1979 Dec;22(12):1469-75. doi: 10.1021/jm00198a008.
In order to define the structural requirements of N-substituents of 2-aminotetralins as central dopamine receptor agonists, a series of N-alkyl- and N,N-dialkyl-substituted 2-amino-5-hydroxy- and 2-amino-5-methoxytetralins have been synthesized and evaluated. The compounds were tested biochemically and behaviorally for dopaminergic activity. From the biochemical data it is concluded that an n-propyl group on the nitrogen is optimal for activity. The corresponding N-ethyl-substituted compounds are slightly less active, while the absence of N-ethyl or N-propyl groups give almost inactive compounds. It could be demonstrated that this is due to steric and not to lipophilic factors. It is suggested that a possible requirement for a potent agonist is that one of it N substituents must fit into a receptor cavity which, because of its size, can maximally accommodate an n-propyl but also smaller groups like ethyl or methyl. The active compounds appeared to give a similar relative pre- and postsynaptic stimulation and had also similar activities for the limbic system and for striatum. None of the compounds listed seemed to have central noradrenaline- or serotonin-receptor stimulating activity.
为了确定作为中枢多巴胺受体激动剂的2-氨基四氢萘N-取代基的结构要求,已合成并评估了一系列N-烷基和N,N-二烷基取代的2-氨基-5-羟基四氢萘和2-氨基-5-甲氧基四氢萘。对这些化合物进行了多巴胺能活性的生化和行为测试。从生化数据得出结论,氮上的正丙基对活性是最佳的。相应的N-乙基取代的化合物活性略低,而没有N-乙基或N-丙基的化合物几乎没有活性。可以证明这是由于空间位阻而非亲脂性因素。有人提出,强效激动剂的一个可能要求是其N取代基之一必须适合受体腔,由于其大小,该受体腔最多可容纳正丙基,但也可容纳较小的基团,如乙基或甲基。活性化合物似乎能产生类似的相对突触前和突触后刺激,并且对边缘系统和纹状体也具有类似的活性。所列化合物似乎均无中枢去甲肾上腺素或血清素受体刺激活性。